Chembio Diagnostics, Inc.
CEMIDelisted Apr 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001092662
Chembio Diagnostics, Inc. was delisted on Apr 27, 2023; its insiders filed their last Form 4 on May 2, 2023; 30 institutions reported holding it in 13F filings for Q1 2023, worth $1.36M in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Chembio Diagnostics, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 36 | 1 | 38 | +3 |
| Shares | 2.84M | 206.4K | 2.42M | −215.5K (−8.2%) |
| Value | $2.32M | $169.0K | $1.57M | −$582.8K (−27.0%) |
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (5)
Institutions that held Chembio Diagnostics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Securities, LLC | 46,046 | $30.0K | 0.01% |
| Renaissance Technologies LLC | 23,500 | $15.0K | 0.00% |
| StoneX Group Inc. | 16,435 | $10.7K | 0.00% |
| Citigroup Inc | 2,200 | $1.00K | 0.00% |
| Riggs Asset Managment Co. Inc. | 1,000 | $1.00K | 0.00% |
Sold out (2)
Institutions that held Chembio Diagnostics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Penbrook Management LLC | 83,450 | $68.0K |
| Virtu Financial LLC | 37,077 | $30.0K |
Not filed for Q2 2022 yet (1)
Institutions that held Chembio Diagnostics, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Susquehanna Fundamental Investments, LLC | 206,419 | $169.0K |